Pro/anti-inflammatory cytokines in the pathogenesis of premature coronary artery disease

Journal of Interferon and Cytokine Research

Volumn 31, Issue 7, 2011, Pages 561-567

  Khan, Dilshad Ahmed ^a   Ansari, Wafa Munir ^a   Khan, Farooq Ahmed ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 79960136117     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0157     Document Type: Article

References (37)

1. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. 2000. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Lancet 356(9226):279-284. (Pubitemid 30459585)
2. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. 1998. Evaluation of C-reactive protein,an inflammatory marker and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32:35.
3. Arroyo-Espliguero R, Avanzas P, Cosfn-Sales J, Aldama G, Pizzi C, Kaski JC. 2004. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eu Heart J 25(5):401-408. (Pubitemid 38391522)
4. Biswas S, Ghoshal PK, Mandal SC, Mandal N. 2010. Relation of anti-to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J Intern Med 25:44-50.
5. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. 2004. Inhibition of tumor necrosis factor-a reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24(11):2137-2142. (Pubitemid 39482442)
6. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. 2003. Influence of interferon-/on the extent and phenotype of diet-induced atherosclerosis in the LDLRdeficient mouse. Arterioscler Thromb Vasc Biol 23(3J):454-460. (Pubitemid 36337222)
7. Camargo PV, Roman RM, Rossini APW, Dedonelli A, Stella SF, Meotti C, Giaretta T, Gasparin A, Polanczyk CA. 2007. Abstract 2872: Interleukin-18/ interleukin-10 ratio is an independent predictor of cardiovascular events in patients with stable coronary artery disease. Circulation 116:II-639.
8. Canault M, Peiretti F, Kopp F, Bonardo B, Bonzi MF, Coudeyre JC, Alessi MC, Juhan-Vague I, Nalbone G. 2006. The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: Possible contribution to elevated plasma levels of soluble TNF alpha receptors. Atheroscler J 187:82-91. (Pubitemid 43833358)
9. Chalikias GK, Tziakas DN, Kaski JC, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris A, Hatseras DI. 2005. Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis 182(1):135-143. (Pubitemid 41188379)
10. Chong LI, Xi-long Z, Hao L, Zhi-gang W, Kai-sheng Y. 2009. Association among plasma interleukin-18 levels, carotid intima-media thickness and severity of obstructive sleep apnea. Chin Med J 122(1):24-29.
11. De Nooijer R, von der Thusen JH, Verkleij CJN, Kuiper J, Jukema JW, van der Wall EE, van Berkel ThJC, Biessen EAL. 2004. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-Edeficient mice. Arterioscler Thromb Vasc Biol 24:2313-2319. (Pubitemid 39658035)
12. Egred M, Viswanathan G, Davis GK. 2005. Myocardial infarction in young adults. Postgrad Med J 81(96):741-745. (Pubitemid 41826595)
13. Fernandez RP and Juan Carlos Kaski JC. 2002. Interleukin-10 and coronary disease. Rev Esp Cardiol 55(7):738-750. (Pubitemid 34873970)
14. Gensini GG. 1983. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606-607.
15. Goswami B, Rajappa M, Mallika V, Shukla DK, Kumar S. 2009. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction. Clin Chim Acta 408(1-2):14-18.
16. Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, Novikov Y, Masrawa S, Soskolne A, Lotan C. 2008. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: Indicators of an active inflammatory burden? Isr Med Assoc J 10(7):494-498.
17. Hulthe J, McPheat W, Samnegard A, Tornvall P, Hamsten A, Eriksson P. 2006. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 188(2):450-454. (Pubitemid 44313924)
18. Jafary HM, Samad A, Ishaq M, Jawaid AS, Ahmad M, Vohra AE. 2007. Profile of acute myocardial infarction in Pakistan. Pak J Med Sc 23(4):485-489. (Pubitemid 47367337)
19. Kirbis S, Breskvar UD, Sabovic M, Zupan I, and Sinkovic A. 2010. Inflammation markers in patients with coronary artery disease-Comparison of intracoronary and systemic levels. Wiener Klinische Wochenschrift 122(2):31-34.
20. Kosmala W, Derzhko R, Przewlocka-Kosmala M, Orda A, Mazurek W. 2008. Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 19(6):375-382.
21. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. 2006. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 367:1747-1757. (Pubitemid 43767064)
22. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. 2001. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:1598-1603. (Pubitemid 32947520)
23. Mills R, Bhatt DL. 2004. The Yin and Yang of arterial inflammation. J Am Coll Cardiol 44:50-52. (Pubitemid 38968455)
24. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, Taniguchi H, Nagata M, Nakamura H, Ohsuzu F. 2010. Associations between plasma C-reactive protein levels and the severity of coronary and aortic atherosclerosis. Adv Publ J Atheroscler Thromb 17:460-467.
25. Pasceri V, Chang J, Willerson JT, Yeh ET. 2001. Modulation of Creactive protein mediated monocyte chemoattractant protein-1 induction in human endothelial calls by anti-atherosclerosis drugs. Circulation 103:2531.
26. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. 2002. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 90(10):1064-1071. (Pubitemid 34627904)
27. Prahl U, Wikstrand J, Bergstrom GM, Behre CJ, Hulthe J, Fagerberg B. 2010. Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance. Angiology 61(8):793-801.
28. Puranik R, Fox OJ, Sullivan DS, Duflou J, Bao S. 2010. Inflammatory characteristics of premature coronary artery disease. Int J Cardiol 145(2):288-290.
29. Sahar S, Dwarakanath RS, Reddy MA, Lanting L, Todorov I, Natarajan R. 2005. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells-A novel cross-talk in the pathogenesis of atherosclerosis. Circ Res 96:1064-1071. (Pubitemid 40791378)
30. Samnegard A, Hulthe J, Silveira A, Ericsson CG, Hamsten A, Eriksson P. 2009. Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients. Atherosclerosis 202:550-556.
31. Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B. 2009. How much is too much-Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 102:215-222.
32. Schultz DR, Arnold PI. 1990. Properties of four acute phase proteins: CRP, serum amyloid a protein, alpha 1-acid glycoprotein and fibrinogen. Semin Arthritis Rheum 20:12947.
33. Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL. 2007. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 99(7):879-884. (Pubitemid 46483272)
34. Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova T, Tesar D, Honek T. 2002. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13(3):151-154. (Pubitemid 34747962)
35. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J. 1999. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the Bruneck Study. J Am Coll Cardiol 34:1975-1981. (Pubitemid 30002653)
36. Yearley JH, Xia D, Pearson C, Carville A, Shannon RP, Mansfield KG. 2009. Interleukin-18 predicts atherosclerosis progression in SIV infected and uninfected rhesus monkeys (Macaca mulatta) on a high fat/high cholesterol diet. Lab Invest 89(6): 657-667.
37. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, Chilian WM. 2006. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 26:475-480.